Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Queensland Health
Boehringer Ingelheim
Argus Health
Chinese Patent Office
Federal Trade Commission

Generated: December 13, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Zolmitriptan, and when can generic versions of Zolmitriptan launch?

Zolmitriptan is a drug marketed by Alembic Pharms Ltd, Apotex Inc, Glenmark Generics, Jubilant Generics, Macleods Pharms Ltd, Zydus Pharms Usa Inc, Ajanta Pharma Ltd, Appco Pharma Llc, Aurobindo Pharma Ltd, Invagen Pharms, Mylan Pharms Inc, Pld Acquisitions Llc, Sun Pharma Global, and Teva Pharms Usa. and is included in nineteen NDAs.

The generic ingredient in ZOLMITRIPTAN is zolmitriptan. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms IncZOLMITRIPTANzolmitriptanTABLET;ORAL203186-002May 14, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Jubilant GenericsZOLMITRIPTANzolmitriptanTABLET;ORAL202279-002Nov 20, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pld Acquisitions LlcZOLMITRIPTANzolmitriptanTABLET;ORAL207867-001Feb 27, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Macleods Pharms LtdZOLMITRIPTANzolmitriptanTABLET;ORAL203772-001Sep 30, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Alembic Pharms LtdZOLMITRIPTANzolmitriptanTABLET, ORALLY DISINTEGRATING;ORAL205074-001Dec 1, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Apotex IncZOLMITRIPTANzolmitriptanTABLET;ORAL202078-002May 14, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glenmark GenericsZOLMITRIPTANzolmitriptanTABLET;ORAL201779-002May 14, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Jubilant GenericsZOLMITRIPTANzolmitriptanTABLET, ORALLY DISINTEGRATING;ORAL202956-001Sep 17, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalZOLMITRIPTANzolmitriptanTABLET;ORAL203476-002Nov 13, 2014DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Apotex IncZOLMITRIPTANzolmitriptanTABLET, ORALLY DISINTEGRATING;ORAL202476-002May 14, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: